Abstract | RATIONALE AND OBJECTIVES: Desensitization of neuronal nicotinic acetylcholine receptors holds promise as an effective treatment of tobacco addiction. Previously, we found that sazetidine-A (Saz-A), which selectively desensitizes α4β2 nicotinic receptors, significantly decreased intravenous (IV) nicotine self-administration (SA) in rats with an effective dose of 3 mg/kg in acute and repeated injection studies. We also found that chronic infusions of Saz-A at doses of 2 and 6 mg/kg/day significantly reduced nicotine SA in rats. In continuing studies, we have characterized other Saz-A analogs, YL-2-203 and VMY-2-95, to determine their efficacies in reducing nicotine SA in rats. METHODS: Young adult female Sprague-Dawley rats were fitted with IV catheters and were trained for nicotine SA (0.03 mg/kg/infusion) on a fixed ratio 1 schedule for ten sessions. The same rats were also implanted subcutaneously with osmotic minipumps to continually deliver 2 or 6 mg/kg body weight YL-2-203, VMY-2-95, or saline for four consecutive weeks. RESULTS: Chronic administration of VMY-2-95 at doses of 2 and 6 mg/kg/day caused significant (p < 0.01) decreases in nicotine SA over the 2 weeks of continued nicotine SA and for the 1-week period of resumed access after a week of enforced abstinence, whereas chronic administration of YL-2-203 at the same doses was not found to be effective. CONCLUSIONS: These studies, together with our previous studies of Saz-A, revealed a spectrum of efficacies for these α4β2 nicotinic receptor desensitizing agents and provide a path forward for the most effective compounds to be further developed as possible aids to smoking cessation.
|
Authors | Amir H Rezvani, Susan Slade, Corinne Wells, Venkata M Yenugonda, Yong Liu, Milton L Brown, Yingxian Xiao, Kenneth J Kellar, Edward D Levin |
Journal | Psychopharmacology
(Psychopharmacology (Berl))
Vol. 234
Issue 17
Pg. 2517-2523
(Sep 2017)
ISSN: 1432-2072 [Electronic] Germany |
PMID | 28555315
(Publication Type: Journal Article)
|
Chemical References |
- 3-(azetidin-2-ylmethoxy)-5-(phenylethynyl)pyridine
- Azetidines
- Nicotinic Agonists
- Nicotinic Antagonists
- Pyridines
- Receptors, Nicotinic
- nicotinic receptor alpha4beta2
- Nicotine
|
Topics |
- Animals
- Azetidines
(administration & dosage)
- Behavior, Animal
(drug effects)
- Dose-Response Relationship, Drug
- Female
- Nicotine
(administration & dosage)
- Nicotinic Agonists
(administration & dosage)
- Nicotinic Antagonists
(administration & dosage)
- Pyridines
(administration & dosage)
- Rats
- Rats, Sprague-Dawley
- Receptors, Nicotinic
- Self Administration
|